Profound talks up Tulsa procedure milestone in Texas

Executive Summary

• Profound Medical Corp. announced that Texas Prostate, led by Dr. James Cochran, has successfully completed its 100th Tulsa procedure using the Tulsa-Pro system.
• The milestone was achieved at Dallas Medical Center’s MRI suite, marking a significant adoption of the technology in a hospital setting.
• Following a transition from a private-pay model to a Medicare-participating model via collaboration with Dallas Medical Center, Texas Prostate reported a 500% increase in Tulsa procedure volumes.

Key Details

• Milestone: Texas Prostate achieved its 100th Tulsa procedure.
• Location: Dallas Medical Center’s state-of-the-art MRI suite.
• Technology: Tulsa-Pro system (robotically controlled directional ultrasound with real-time MRI thermography).
• Clinical Application: Treatment for prostate cancer and/or benign prostatic hyperplasia (BPH).
• Adoption Metrics:
  • Transitioned from private-pay to Medicare model via collaboration with Dallas Medical Center.
  • Procedure numbers increased by 500% immediately upon transitioning to the Medicare model.
  • Continued growth in enquiries from Texas and surrounding states.
  • Increasing interest from urologists in the Dallas-Fort Worth metroplex.
• Procedure Benefits Highlighted:
  • Continuous, in-bore MRI visualization for precise tumor location and extent.
  • No procedural blood loss.
  • No overnight hospital stay.
  • Quicker return to everyday life.
  • Minimized side effects (urinary incontinence and/or erectile dysfunction) compared to surgery or radiation.
• Company Context: Profound Medical is a commercial-stage medical device company innovating in interventional MRI procedures. Its flagship platform, Tulsa-Pro, is cleared or approved in the US, Europe, Canada, Saudi Arabia, India, Australia/New Zealand, and the UAE.

Notable Quotes

• Dr. James Cochran (Texas Prostate): "Almost immediately upon transitioning from a private pay to a Medicare model via our new collaboration with Dallas Medical Center, our Tulsa procedure numbers increased by 500 per cent and continue to grow as new enquiries from around Texas and surrounding states come in every day and urologists in the Dallas-Fort Worth metroplex reach out to learn how to offer Tulsa to their patients."
• Arun Menawat (CEO and Chairman, Profound Medical): "Under this innovative model pioneered by Texas Prostate -- bridging private-pay practices and Medicare-participating hospitals -- Dr. Cochran is demonstrating a way for urologists to accelerate adoption of the next generation of prostate care by allowing more men to benefit from the Tulsa procedure's versatility across the full spectrum of prostate disease."